ArticleJACC. Case reports2025
Mavacamten for Left Ventricular Outflow Tract Obstruction After Successful Transcatheter Aortic Valve Implantation.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Systolic Anterior Motion and Dynamic Mitral Regurgitation Following SAVR: A Case of Hemodynamic Optimization Over Intervention.Echocardiography (Mount Kisco, N.Y.) · 2026Article
- Mavacamten in Symptomatic Patients Resistant to Previous Advanced Therapy for Obstructive Hypertrophic Cardiomyopathy.Journal of the American Heart Association · 2025Article
- Update on left ventricular outflow tract obstruction.Journal of cardiovascular imaging · 2025Review
- Left Ventricular Outflow Tract Obstruction After Transcatheter Aortic Valve Replacement: Seeking Optimal Treatment.JACC. Case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemodynamically significant left ventricular outflow tract obstruction is a rare complication of transcatheter aortic valve implantation (TAVI). This study presents an unusual case of a patient who, after a successful TAVI, developed and experienced progressive worsening of severe left ventricular outflow tract obstruction after uneventful TAVI that was effectively relieved using mavacamten.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.